Measles Elimination Successful and Its Relevant Challenges in Iran

Seyed Abbas Hosseinalipour, Abolfazl Mohammadbeigi, Siamak Mohebi, Abedin Saghafipour, Amin Arabshahi, Farzaneh Mahdianpour


Measles is an infectious childhood disease with some death annually. The expansion of the coverage of vaccination plan has significantly reduced the mortality rate of this disease. Given that the endemic measles virus is not transmitted in the country and based on Regional Verification Commission (RVC) for Measles and Rubella Elimination has declared that measles and rubella have been eliminated in three countries of Eastern Mediterranean Region including Islamic Republic of Iran, Bahrain, and Oman. Therefore, to continue and preventing from reemerging of measles in Iran, it is essential to maintaining the immunization programs, diagnose, and investigate all suspicious cases and outbreaks. This article investigates the challenges facing to measles after elimination declaration in Iran. However, the elimination of these diseases to be sustainable needs a vigorous case identification protocol and contact follow up.


Elimination; measles; outbreak; syndromic surveillance system; vaccination

Full Text:



Zahraei M, Dadras MN, Sabori A. National Guideline for

Measles Surveillance (elimination phase). 2nd ed. Tehran, Iran:

Andishmand Publications; 2010. [In Persian].

Perry RT, Halsey NA. The clinical significance of measles:

A review. J Infect Dis 2004;189:S4‑16.

Nandy R, Handzel T, Zaneidou M, Biey J, Coddy RZ, Perry R,

et al. Case‑fatality rate during a measles outbreak in eastern

Niger in 2003. Clin Infect Dis 2006;42:322‑8.

WHO, Unicef. Joint statement: Global plan for reducing measles

mortality 2006‑2010. WHO/IVB/0.5.11, January 2006. Available


en/index3.html. [Last accessed on 2021 Mar 04].

Sanyaolu A, Okorie C, Marinkovic A, Ayodele O, Abbasi AF,

Prakash S, et al. Measles outbreak in unvaccinated and

partially vaccinated children and adults in the United States

and Canada (2018‑2019): A narrative review of cases. Inquiry

;56:46958019894098. doi: 10.1177/0046958019894098.

WHO. WHO declares countries measles and rubella free.

Available from:

rvc‑declared‑bahrain‑oman‑iran‑rubella‑measles‑free.html. [Last

accessed on 2019 Dec 18].

Zahraei SM, Eshrati B, Gouya MM, Mohammadbeigi A,

Kamran A. Is there still an immunity gap in high‑level national

immunization coverage, Iran? Arch Iran Med 2014;17:698‑701.

Karami M, Zahraei SM, Sabouri A, Soltanshahi R, Biderafsh A,

Piri N, et al. Documentation of measles elimination in Iran:

Evidences from 2012 to 2014. J Res Health Sci 2017;17:e00387.

Rejali M, Mohammadbeigi A, Mokhtari M, Zahraei SM,

Eshrati B. Timing and delay in children vaccination; evaluation

of expanded program of immunization in outskirt of Iranian

cities. J Res Health Sci 2015;15:54‑8.

Siavashi MR, Mostafavi E, Noori A. Guideline for Investigation

and Response to Communicable Disease Outbreaks. 1st ed.

Tehran, Iran: Andishmand Publications; 2010. [In Persian].

Mohammadbeigi A, Zahraei SM, Asgarian A, Afrashteh S,

Mohammadsalehi N, Khazaei S, et al. Estimation of measles risk

using the World Health Organization Measles Programmatic Risk

Assessment Tool, Iran. Heliyon 2018;4:e00886.

Moradi G, Asadi H, Gouya MM, Nabavi M, Norouzinejad A,

Karimi M, et al. The communicable diseases surveillance

system in Iran: Challenges and opportunities. Arch Iran Med


Salimi V, Abbasi S, Zahraei SM, Fatemi‑Nasab G,

Adjaminezhad‑Fard F, Shadab A, et al. Implementation of a

National Measles Elimination Program in Iran: Phylogenetic

analysis of measles virus strains isolated during 2010–2012

outbreaks. PLoS One 2014;9:e94846.

Zahraei SM, Mohammadbeigi A, Mohammadsalehi N,

Sabouri A, Afrashteh S, Arsang Jang S, et al. Monitoring of

surveillance quality indicators of measles in Iranian districts:

Analysis of measles surveillance system 2014‑2016. J Res

Health Sci 2018;18:e00418.

Carrieri V, Madio L, Principe F. Vaccine hesitancy and (fake)

news: Quasi‑experimental evidence from Italy. Health Econ


MacDonald NE, SAGE Working Group on Vaccine Hesitancy.

Vaccine hesitancy: Definition, scope and determinants. Vaccine


World Health Organization (WHO). Measles Risk Assessment

Tool, Setup guide. 2017. Available from: https://www.who.


Risk_Assessment_Tool_setup_guide_V1.5_EN.pdf?ua=1. [Last

accessed on 2021 Mar 04].